Filing Details

Accession Number:
0001179110-12-017433
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-12 17:12:17
Reporting Period:
2012-12-10
Filing Date:
2012-12-12
Accepted Time:
2012-12-12 17:12:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1501589 David A. Forrest 100 Abbott Park Road
Abbott Park IL 60064
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2012-12-10 5,700 $52.54 40,715 No 4 M Direct
Common Shares Without Par Value Acquisiton 2012-12-10 6,200 $55.56 46,915 No 4 M Direct
Common Shares Without Par Value Acquisiton 2012-12-10 9,568 $51.74 56,483 No 4 M Direct
Common Shares Without Par Value Acquisiton 2012-12-10 13,867 $46.60 70,350 No 4 M Direct
Common Shares Without Par Value Disposition 2012-12-10 47,286 $65.10 23,064 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Acquisiton 2012-12-10 5,700 $0.00 5,700 $52.54
Common Shares Option (right to buy) Acquisiton 2012-12-10 6,200 $0.00 6,200 $55.56
Common Shares Option (right to buy) Acquisiton 2012-12-10 9,568 $0.00 9,568 $51.74
Common Shares Option (right to buy) Acquisiton 2012-12-10 13,867 $0.00 13,867 $46.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-02-16 2017-02-15 No 4 M Direct
0 2011-02-15 2018-02-14 No 4 M Direct
4,782 2012-09-17 2020-09-16 No 4 M Direct
27,733 2012-02-18 2021-02-17 No 4 M Direct
Footnotes
  1. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
  2. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.